However, even though cyclopentenyl uracil and other UCK and dCK inhibitors were identified and their potential use as anti-cancer agents was proposed, this approach was not followed up until recently with the discovery of the link between dCK and replication stress in acute lymphoblastic leukemia (ALL). The gene discussed is DCK; the disease is acute lymphoblastic leukemia.